Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 8e-06 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |